Genotype–phenotype correlation in BRCA1/2 mutation-associated pancreatic cancer

Pancreatic cancers occurring in carriers of a pathogenic germline alteration in BRCA1/2 (gBRCA1/2) are assumed to demonstrate homologous recombination repair deficiency (HRD), associated with sensitivity to platinum-based chemotherapy and synthetic lethality with PARP inhibitors (PARPi). However, pr...

Descripción completa

Detalles Bibliográficos
Autor principal: Lowery, Maeve A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Editorial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7000729/
https://www.ncbi.nlm.nih.gov/pubmed/31787750
http://dx.doi.org/10.1038/s41416-019-0645-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7000729/
https://www.ncbi.nlm.nih.gov/pubmed/31787750
http://dx.doi.org/10.1038/s41416-019-0645-9

Ejemplares similares